June 1 (Reuters) - The U.S. Food and Drug Administration said on Thursday it has revoked the emergency use authorization for Johnson & Johnson's COVID-19 vaccine. (Reporting by Bhanvi Satija in Bengaluru)
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
149.3 USD | -0.43% | +2.14% | -4.77% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.77% | 359B | |
+26.08% | 662B | |
+21.92% | 546B | |
+16.97% | 323B | |
+5.69% | 289B | |
+13.68% | 234B | |
+4.60% | 198B | |
-10.59% | 194B | |
+8.08% | 167B | |
-3.40% | 157B |
- Stock Market
- Equities
- JNJ Stock
- News Johnson & Johnson
- US FDA revokes emergency use authorization for J&J's COVID vaccine